Innovation in Tuberculosis (INNOVA4TB)
Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER)
Listed as NCT04002869, this observational or N/A phase trial focuses on Tuberculosis and remains ongoing. Sponsored by Consorcio Centro de Investigación Biomédica en Red (CIBER), it has been updated 7 times since 2019, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Oct 2021 — Mar 2023 [monthly]
Recruiting
-
Mar 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Aug 2019 — Jan 2021 [monthly]
Recruiting
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Consorcio Centro de Investigación Biomédica en Red (CIBER)
- EMPE DIAGNOSTICS AB
- Fundació Institut Germans Trias i Pujol
- Genome Identification Diagnostics GmbH
- INSTITUTUL DE FTIZIOPNEUMOLOGIE CHIRIL DRAGANIUC
- MAGRITEK GMBH
- North-Western State Medical University named after I.I.Mechnikov
- ODESA SIGNIFICANT DISEASES CENTER
- SERVICIOS CLINICOS SA
- Umeå University
- Universidad de La Frontera
- Vinnitsa National Medical University
For direct contact, visit the study record on ClinicalTrials.gov .